Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Copy service |  |
|---|---|
| Related links |  |
| Publisher site |  |
Art
J-GLOBAL ID：202002271207528868
Reference number：20A1607414 Recent advance in the molecular mechanisms of hepatic glucose production.
糖・エネルギー代謝ネットワークupdate 肝臓による糖産生の制御update
ClipsReference (13)
- Ambery P, Parker VE, Stumvoll M, et al. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes : a randomised, controlled, double-blind, ascending dose and phase 2a study. Lancet 2018 ; 391 : 2607.
- Perry RJ, Camporez JG, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015 ; 160: 745.
- Gerhart-Hines Z, Dominy JE Jr, Blättler SM, et al. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Mol Cell 2011 ; 44 : 851.
- Sakai M, Tujimura-Hayakawa T, Yagi T, et al. The GCN5-CITED2-PKA signalling module controls hepatic glucose metabolism through a cAMP-induced substrate switch. Nat Commun 2016 ; 7 : 13147.
- Wang Y, Li G, Goode J, et al. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Nature 2012 ; 485: 128.
- Ozcan L, Wong CC, Li G, et al. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 2012 ; 15 : 739.
- Perry RJ, Zhang D, Guerra MT, et al. Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis. Nature 2020 ; 579 : 279.
- Young SG, Zechner R. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev 2013 ; 27 : 459.
- O’Neill B, Simha V, Kotha V, et al. Body fat distribution and metabolic variables in patients with neonatal progeroid syndrome. Am J Med Genet A 2007 ; 143A : 1421.
- Romere C, Duerrschmid C, Bournat J, et al. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell 2016 ; 165: 566.
- Duerrschmid C, He Y, Wang C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med 2017 ; 23 : 1444.
- Li E, Shan H, Chen L, et al. OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin. Cell Metab 2019 ; 30 : 319.
- Andermann ML, Lowell BB. Toward a Wiring Diagram Understanding of Appetite Control. Neuron 2017 ; 95: 757.
1 to 13 of 13 results
- « Top
- ‹ Prev
- 1
- Next ›
- Last »
